Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Innoviva Inc. (INVA): Billionaire Seth Klarman’s Baupost Group Reduces Stake

An amended 13G filing with the US Securities and Exchange Commission revealed that billionaire Seth Klarman‘s Baupost Group has decreased its stake in Innoviva Inc. (NASDAQ:INVA) to 17.37 million shares, which represent 15.29% of the company’s outstanding stock. According to the fund’s latest 13F filing, its stake previously consisted of 17.61 million shares held at the end of June.

Innoviva, formerly known as Theravance, is a biopharmaceutical company that delivers new medicines to patients in areas of unmet need. Recently, Innoviva and GlaxoSmithKline plc reported positive results from the COPD Salford Lung Study, in which the performance of Relvar® Ellipta® in patients with the chronic obstructive pulmonary disease was being evaluated. Since the beginning of the year, the company’s stock has gained 6.55%. For the second quarter of 2016, Innoviva reported earnings per share of $0.13 and revenue of $32.47 million, compared to a loss per share of $0.07 and revenue of $10.65 million for the same quarter in the previous year.


According to Insider Monkey’s hedge fund database, 20 investors were long Innoviva (NASDAQ:INVA) at the end of June, compared to 18 smart money managers in the previous quarter. Some of the bullish investors included David Cohen and Harold Levy’s Iridian Asset Management, with a position worth around $113.65 million, Allan Teh’s Kamunting Street Capital, which held a position valued at $7 million in BOND options, Jean-Marie Eveillard’s First Eagle Investment Management, and Glenn Russell Dubin’s Highbridge Capital Management.

Follow Innoviva Inc. (NASDAQ:INVA)
Trade (NASDAQ:INVA) Now!

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
The Baupost Group 0 17,371,043 0 17,371,043 17,371,043 15.29%
SAK Corporation04-3334541 0 17,371,043 0 17,371,043 17,371,043 15.29%
Seth A. Klarman 0 17,371,043 0 17,371,043 17,371,043 15.29%

Seth Klarman
Seth Klarman
Baupost Group

Page 1 of 5 – SEC Filing

D.C. 20549
the Securities Exchange Act of 1934

(Amendment No.
Innoviva, Inc. 

of Issuer)
Common Stock

(Title of Class of Securities)


(CUSIP Number)

August 31, 2016

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:



The remainder of this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
information required in the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the

Follow Innoviva Inc. (NASDAQ:INVA)
Trade (NASDAQ:INVA) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.